MedPacto, Inc.
KOE: 235980.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Seong-Jin Kim
- Employees
- 56
- Headquarters
- Seoul, South Korea
- IPO year
- 2019
- Market cap
- ₩167.6B
- Website
- http://www.medpacto.com
Loading 235980…
Loading profile data…Frequently asked questions about 235980
What does MedPacto, Inc. (235980.KQ) do?
MedPacto, Inc., a drug discovery and development company, develops and delivers therapeutics targeting cancer and autoimmune diseases in South Korea. The company is developing ME-1601mAb that targets BSP1 for cancers; MS-1601A that targets TRG1 for cancers and autoimmune diseases; and vactosertib for solid tumors. MedPacto, Inc. is based in Seou...
Where does 235980.KQ trade?
MedPacto, Inc. (235980.KQ) trades on the KOSDAQ.
What sector is 235980.KQ in?
MedPacto, Inc. (235980.KQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of MedPacto, Inc.?
Seong-Jin Kim is the chief executive officer of MedPacto, Inc. (235980.KQ).
Where is MedPacto, Inc. headquartered?
MedPacto, Inc. is headquartered in South Korea.
Does 235980.KQ pay a dividend?
MedPacto, Inc. (235980.KQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 235980.KQ go public?
MedPacto, Inc. (235980.KQ) completed its initial public offering in 2019.